Human Peptide Hormone
Active Substance: CJC-1295 DAC
Manufacturer: Dragon Pharma
Unit: 2 mL Vial (5 mg/vial)
CJC-1295 DAC is commonly known by its scientific name, CJC-1295 DAC, and is recognized as a potent peptide used in the realm of sports performance and bodybuilding.
CJC-1295 DAC, manufactured by Dragon Pharma, is a synthetic peptide designed to enhance growth hormone secretion. Enclosed in a 2 mL vial, each dose contains 5 mg of the active substance CJC-1295 DAC.
Each vial of CJC-1295 DAC contains a 5 mg dosage of the active substance, CJC-1295 DAC. The formulation is meticulously crafted to ensure purity and potency.
CJC-1295 DAC is widely appreciated in bodybuilding for its ability to stimulate the release of growth hormone, leading to increased muscle mass, improved fat metabolism, and enhanced recovery. It offers athletes a natural means to optimize their physical performance.
While primarily used in bodybuilding, CJC-1295 DAC may have therapeutic applications in addressing growth hormone deficiencies and related conditions.
The recommended dosage for men using CJC-1295 DAC typically ranges from 500 mcg to 1000 mcg per week, divided into multiple administrations. This peptide is often administered in conjunction with a growth hormone releasing peptide (GHRP) for enhanced efficacy.
The dosage for women is generally similar to that of men. However, due to individual variations, it is crucial for women to start with lower doses (around 500 mcg per week) and monitor their response carefully.
CJC-1295 DAC has a prolonged active life, allowing for less frequent administration. The peptide's half-life is extended due to the addition of the Drug Affinity Complex (DAC), leading to a sustained release of growth hormone.
Common side effects of CJC-1295 DAC may include temporary redness or irritation at the injection site. However, adverse reactions are generally mild and temporary.
Individuals with a history of hypersensitivity to peptides or those with pre-existing medical conditions should exercise caution. Consultation with a healthcare professional is advised before starting any regimen involving CJC-1295 DAC.
While overdosage is rare, exceeding recommended doses may increase the risk of side effects. In case of suspected overdosage, medical attention should be sought promptly.
Creating an effective stack or cycle with CJC-1295 DAC involves combining it with other peptides to maximize growth hormone release and overall benefits. Here's a detailed example of a CJC-1295 DAC cycle, including the names of products and their recommended dosages:
Cycle Duration: 12 weeks
Weeks 1-12: CJC-1295 DAC and Ipamorelin
CJC-1295 DAC: 500 mcg per week (divided into two or three doses)
Ipamorelin: 100 mcg per week (administered at the same time as CJC-1295 DAC)
Note: Combining CJC-1295 DAC with Ipamorelin enhances the pulsatile release of growth hormone, promoting optimal muscle growth and fat metabolism.
Weeks 1-6: CJC-1295 DAC, Ipamorelin, and Mod GRF 1-29
CJC-1295 DAC: 500 mcg per week
Ipamorelin: 100 mcg per week
Mod GRF 1-29: 100 mcg per week (administered at the same time as CJC-1295 DAC)
Note: Introducing Mod GRF 1-29 during the first six weeks complements the effects of CJC-1295 DAC and Ipamorelin, providing a synergistic boost to growth hormone release.
Weeks 7-12: CJC-1295 DAC, Ipamorelin, and GHRP-6
CJC-1295 DAC: 500 mcg per week
Ipamorelin: 100 mcg per week
GHRP-6: 100 mcg per week (administered at the same time as CJC-1295 DAC)
Note: Incorporating GHRP-6 in the latter part of the cycle further amplifies growth hormone secretion, promoting sustained anabolic effects.
Post-Cycle Therapy (PCT):
While peptides like CJC-1295 DAC typically do not require a traditional PCT, it's advisable to continue with a simplified protocol to support overall hormonal balance.
HCG (Human Chorionic Gonadotropin): 500 IU per week for 4 weeks.
Aromasin (Exemestane): 12.5 mg every other day for 4 weeks.
Note: This post-cycle therapy is optional and should be considered based on individual response and the intensity of the peptide cycle.
Additional Cycle Notes:
Nutrition and Training: Maintain a well-balanced diet rich in protein and engage in a structured resistance training program to optimize results.
Hydration: Adequate hydration is essential during the cycle to support overall health and recovery.
Regular Monitoring: Periodic health check-ups, including hormone panels, are recommended to monitor individual response and adjust dosages if necessary.
Individual Adjustments: Dosages and cycle lengths may need to be adjusted based on individual goals, response, and experience level. Consultation with a healthcare professional is essential.
It's crucial to note that the information provided is for educational purposes, and individuals considering such peptide cycles should consult with a healthcare professional experienced in peptide therapy.
CJC-1295 DAC is available in a 2 mL vial, providing a convenient and precise means of administration. Each vial is labeled with dosage information and manufactured by Dragon Pharma.
To maintain stability and potency, CJC-1295 DAC should be stored in a cool, dry place, away from direct sunlight and extreme temperatures. Proper storage ensures the integrity of the peptide until the expiration date.
i want to give that steriod
Human Peptide Hormone
Active Substance: Pentadecapeptide
Manufacturer: Dragon Pharma
Unit: 2 mL Vial (2 mg/vial)
Form: Powder
Laboratory Tested: 2024-03-22
Water for Injection
Active Substance: Sterile Water
Manufacturer: Dragon Pharma
Unit: 10 mL Vial (0.9%/vial)
Peptide Hormone
Active Substance: Ipamorelin
Manufacturer: Dragon Pharma
Unit: 2 mL Vial (5 mg/vial)
Laboratory Tested: 2023-11-20
Melanotropin Peptide
Active Substance: Melanotan 2
Manufacturer: Dragon Pharma
Unit: 2 mL Vial (10 mg/vial)
Laboratory Tested: 2023-11-20
Research Peptide for Erectile Dysfunction
Active Substance: Bremelanotide
Manufacturer: Dragon Pharma
Unit: 2 mL Vial (10 mg/vial)
Human Peptide Hormone
Active Substance: Selank
Manufacturer: Dragon Pharma
Unit: 2 mL Vial (10 mg/vial)
Laboratory Tested: 2023-11-20
Human Peptide Hormone
Active Substance: Semaglutide
Manufacturer: Dragon Pharma
Unit: 2 mL Vial (5 mg/mL)
Form: Powder
Laboratory Tested: 2024-06-17
Human Peptide Hormone
Active Substance: Semax
Manufacturer: Dragon Pharma
Unit: 2 mL Vial (5 mg/vial)
Laboratory Tested: 2023-11-20
Growth Hormone-Releasing Hormone
Active Substance: Sermorelin
Manufacturer: Dragon Pharma
Unit: 2 mL Vial (5 mg/vial)
Peptide Hormone
Active Substance: Thymosin Beta-4
Manufacturer: Dragon Pharma
Unit: 2 mL Vial (5 mg/mL)
Form: Powder
Laboratory Tested: 2024-03-22
Human Peptide Hormone
Active Substance: Tesamorelin
Manufacturer: Dragon Pharma
Unit: 2 mL Vial (5 mg/vial)
Human Peptide Hormone
Active Substance: Tirzepatide
Manufacturer: Dragon Pharma
Unit: 2 mL Vial (5 mg/vial)
Form: Powder
Laboratory Tested: 2024-06-17
Human Peptide Hormone
Active Substance: CJC1295 DAC
Manufacturer: Ultima Pharmaceuticals
Unit: 10 mL Vial (2 mg/vial)
Human Peptide Hormone
Active Substance: CJC1295 w/o DAC
Manufacturer: Ultima Pharmaceuticals
Unit: 10 mL Vial (2 mg/vial)